Skip to main content
Erschienen in:

10.01.2022 | Pancreatic Tumors

Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration

verfasst von: Jonathan Pastrana Del Valle, MD, Nathanael R. Fillmore, PhD, George Molina, MD, MPH, Mark Fairweather, MD, Jiping Wang, MD, PhD, Thomas E. Clancy, MD, Stanley W. Ashley, MD, Richard D. Urman, MD, Edward E. Whang, MD, Jason S. Gold, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Disparities based on socioeconomic factors such as race, ethnicity, marital status, and insurance status are associated with pancreatic cancer resection, but these disparities are usually not observed for survival after resection. It is unknown if there are disparities when patients undergo their treatment in a non-fee-for-service, equal-access healthcare system such as the Veterans Health Administration (VHA).

Methods

Patients having T1–T3 M0 pancreatic adenocarcinoma diagnosed between 2006 and 2017 were identified from the VHA Corporate Data Warehouse. Socioeconomic, demographic, and tumor variables associated with resection and survival were assessed.

Results

In total, 2580 patients with early-stage pancreatic cancer were identified. The resection rate was 36.5%. Surgical resection was independently associated with younger age [odds ratio (OR) 0.94, p < 0.001], White race (OR 1.35, p = 0.028), married status (OR 1.85, p = 0.001), and employment status (retired vs. unemployed, OR 1.41, p = 0.008). There were no independent associations with Hispanic ethnicity, geographic region, or Social Deprivation Index. Resection was associated with significantly improved survival (median 21 vs. 8 months, p = 0.001). Among resected patients, survival was independently associated with younger age (HR 1.019, p = 0.002), geographic region (South vs. Pacific West, HR 0.721, p = 0.005), and employment (employed vs. unemployed, HR 0.752, p = 0.029). Race, Hispanic ethnicity, marital status, and Social Deprivation Index were not independently associated with survival after resection.

Conclusions

Race, marital status, and employment status are independently associated with resection of pancreatic cancer in the VHA, whereas geographic region and employment status are independently associated with survival after resection. Further studies are warranted to determine the basis for these inequities.
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.PubMedCrossRef Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.PubMedCrossRef
2.
Zurück zum Zitat Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21.PubMedCrossRef Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21.PubMedCrossRef
3.
Zurück zum Zitat Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246(2):173–80.PubMedPubMedCentralCrossRef Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246(2):173–80.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat McGhan LJ, Etzioni DA, Gray RJ, Pockaj BA, Coan KE, Wasif N. Underuse of curative surgery for early stage upper gastrointestinal cancers in the United States. J Surg Res. 2012;177(1):55–62.PubMedCrossRef McGhan LJ, Etzioni DA, Gray RJ, Pockaj BA, Coan KE, Wasif N. Underuse of curative surgery for early stage upper gastrointestinal cancers in the United States. J Surg Res. 2012;177(1):55–62.PubMedCrossRef
5.
Zurück zum Zitat Shaib Y, Davila J, Naumann C, El-Serag H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. population-based study. Am J Gastroenterol. 2007;102(7):1377–82.PubMedCrossRef Shaib Y, Davila J, Naumann C, El-Serag H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. population-based study. Am J Gastroenterol. 2007;102(7):1377–82.PubMedCrossRef
6.
Zurück zum Zitat Shapiro M, Chen Q, Huang Q, et al. Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer. JAMA Surg. 2016;151(4):338–45.PubMedCrossRef Shapiro M, Chen Q, Huang Q, et al. Associations of socioeconomic variables with resection, stage, and survival in patients with early-stage pancreatic cancer. JAMA Surg. 2016;151(4):338–45.PubMedCrossRef
7.
Zurück zum Zitat Bilimoria KY, Bentrem DJ, Tomlinson JS, et al. Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals. Am J Surg. 2007;194(5):588–93.PubMedCrossRef Bilimoria KY, Bentrem DJ, Tomlinson JS, et al. Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals. Am J Surg. 2007;194(5):588–93.PubMedCrossRef
8.
Zurück zum Zitat Khawja SN, Mohammed S, Silberfein EJ, Musher BL, Fisher WE, Van Buren G. Pancreatic cancer disparities in African Americans. Pancreas. 2015;44(4):522–7.PubMedCrossRef Khawja SN, Mohammed S, Silberfein EJ, Musher BL, Fisher WE, Van Buren G. Pancreatic cancer disparities in African Americans. Pancreas. 2015;44(4):522–7.PubMedCrossRef
9.
Zurück zum Zitat Cervantes A, Waymouth EK, Petrov MS. African-Americans and Indigenous Peoples have increased burden of diseases of the exocrine pancreas: a systematic review and meta-analysis. Dig Dis Sci. 2019;64(1):249–61.PubMedCrossRef Cervantes A, Waymouth EK, Petrov MS. African-Americans and Indigenous Peoples have increased burden of diseases of the exocrine pancreas: a systematic review and meta-analysis. Dig Dis Sci. 2019;64(1):249–61.PubMedCrossRef
10.
Zurück zum Zitat Blanco BA, Poulson M, Kenzik KM, McAneny DB, Tseng JF, Sachs TE. The impact of residential segregation on pancreatic cancer diagnosis, treatment, and mortality. Ann Surg Oncol. 2020;28:3147.PubMedCrossRef Blanco BA, Poulson M, Kenzik KM, McAneny DB, Tseng JF, Sachs TE. The impact of residential segregation on pancreatic cancer diagnosis, treatment, and mortality. Ann Surg Oncol. 2020;28:3147.PubMedCrossRef
12.
Zurück zum Zitat Shah A, Chao KS, Ostbye T, et al. Trends in racial disparities in pancreatic cancer surgery. J Gastrointest Surg. 2013;17(11):1897–906.PubMedCrossRef Shah A, Chao KS, Ostbye T, et al. Trends in racial disparities in pancreatic cancer surgery. J Gastrointest Surg. 2013;17(11):1897–906.PubMedCrossRef
13.
Zurück zum Zitat Molina G, Clancy TE, Tsai TC, Lam M, Wang J. Racial disparity in pancreatoduodenectomy for borderline resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2021;28(2):1088–96.PubMedCrossRef Molina G, Clancy TE, Tsai TC, Lam M, Wang J. Racial disparity in pancreatoduodenectomy for borderline resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2021;28(2):1088–96.PubMedCrossRef
14.
Zurück zum Zitat Murphy MM, Simons JP, Ng SC, et al. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16(11):2968–77.PubMedCrossRef Murphy MM, Simons JP, Ng SC, et al. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16(11):2968–77.PubMedCrossRef
15.
Zurück zum Zitat Heller DR, Nicolson NG, Ahuja N, Khan S, Kunstman JW. Association of treatment inequity and ancestry with pancreatic ductal adenocarcinoma survival. JAMA Surg. 2020;155(2):e195047.PubMedCrossRef Heller DR, Nicolson NG, Ahuja N, Khan S, Kunstman JW. Association of treatment inequity and ancestry with pancreatic ductal adenocarcinoma survival. JAMA Surg. 2020;155(2):e195047.PubMedCrossRef
16.
Zurück zum Zitat Riall TS, Townsend CM Jr, Kuo YF, Freeman JL, Goodwin JS. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer. 2010;116(4):930–9.PubMedCrossRef Riall TS, Townsend CM Jr, Kuo YF, Freeman JL, Goodwin JS. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process. Cancer. 2010;116(4):930–9.PubMedCrossRef
17.
Zurück zum Zitat Singal V, Singal AK, Kuo YF. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol. 2012;138(4):715–22.PubMedCrossRef Singal V, Singal AK, Kuo YF. Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis. J Cancer Res Clin Oncol. 2012;138(4):715–22.PubMedCrossRef
18.
Zurück zum Zitat Zhu F, Wang H, Ashamalla H. Racial and socioeconomic disparities in the treatments and outcomes of pancreatic cancer among different treatment facility types. Pancreas. 2020;49(10):1355–63.PubMedCrossRef Zhu F, Wang H, Ashamalla H. Racial and socioeconomic disparities in the treatments and outcomes of pancreatic cancer among different treatment facility types. Pancreas. 2020;49(10):1355–63.PubMedCrossRef
19.
Zurück zum Zitat Liu JH, Zingmond DS, McGory ML, SooHoo NF, Ettner SL, Brook RH, Ko CY. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA. 2006;296(293):1973–80.PubMedCrossRef Liu JH, Zingmond DS, McGory ML, SooHoo NF, Ettner SL, Brook RH, Ko CY. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA. 2006;296(293):1973–80.PubMedCrossRef
20.
21.
Zurück zum Zitat Deville C Jr, Lee WR. Reconciling outcomes for Black men with prostate cancer within and outside the Veterans Health Administration. Cancer. 2021;127(3):342–4.PubMedCrossRef Deville C Jr, Lee WR. Reconciling outcomes for Black men with prostate cancer within and outside the Veterans Health Administration. Cancer. 2021;127(3):342–4.PubMedCrossRef
22.
Zurück zum Zitat Peterson K, Anderson J, Boundy E, Ferguson L, McCleery E, Waldrip K. Mortality disparities in racial/ethnic minority groups in the Veterans Health Administration: an evidence review and map. Am J Public Health. 2018;108(3):e1–11.PubMedPubMedCentralCrossRef Peterson K, Anderson J, Boundy E, Ferguson L, McCleery E, Waldrip K. Mortality disparities in racial/ethnic minority groups in the Veterans Health Administration: an evidence review and map. Am J Public Health. 2018;108(3):e1–11.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Graham-Steed T, Uchio E, Wells CK, Aslan M, Ko J, Concato J. “Race” and prostate cancer mortality in equal-access healthcare systems. Am J Med. 2013;126(12):1084–8.PubMedPubMedCentralCrossRef Graham-Steed T, Uchio E, Wells CK, Aslan M, Ko J, Concato J. “Race” and prostate cancer mortality in equal-access healthcare systems. Am J Med. 2013;126(12):1084–8.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Riviere P, Luterstein E, Kumar A, et al. Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system. Cancer. 2020;126(8):1683–90.PubMedCrossRef Riviere P, Luterstein E, Kumar A, et al. Survival of African American and non-Hispanic white men with prostate cancer in an equal-access health care system. Cancer. 2020;126(8):1683–90.PubMedCrossRef
25.
Zurück zum Zitat Zullig LL, Carpenter WR, Provenzale D, Weinberger M, Reeve BB, Jackson GL. Examining potential colorectal cancer care disparities in the Veterans Affairs health care system. J Clin Oncol. 2013;31(28):3579–84.PubMedPubMedCentralCrossRef Zullig LL, Carpenter WR, Provenzale D, Weinberger M, Reeve BB, Jackson GL. Examining potential colorectal cancer care disparities in the Veterans Affairs health care system. J Clin Oncol. 2013;31(28):3579–84.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Zullig LL, Jackson GL, Weinberger M, Provenzale D, Reeve BB, Carpenter WR. An examination of racial differences in process and outcome of colorectal cancer care quality among users of the veterans affairs health care system. Clin Colorectal Cancer. 2013;12(4):255–60.PubMedCrossRef Zullig LL, Jackson GL, Weinberger M, Provenzale D, Reeve BB, Carpenter WR. An examination of racial differences in process and outcome of colorectal cancer care quality among users of the veterans affairs health care system. Clin Colorectal Cancer. 2013;12(4):255–60.PubMedCrossRef
27.
Zurück zum Zitat Voora RS, Kotha NV, Kumar A, et al. Association of race and health care system with disease stage and survival in veterans with larynx cancer. Cancer. 2021;127:2705.PubMedCrossRef Voora RS, Kotha NV, Kumar A, et al. Association of race and health care system with disease stage and survival in veterans with larynx cancer. Cancer. 2021;127:2705.PubMedCrossRef
28.
Zurück zum Zitat Ganti AK, Subbiah SP, Kessinger A, Gonsalves WI, Silberstein PT, Loberiza FR Jr. Association between race and survival of patients with non-small-cell lung cancer in the United States veterans affairs population. Clin Lung Cancer. 2014;15(2):152–8.PubMedCrossRef Ganti AK, Subbiah SP, Kessinger A, Gonsalves WI, Silberstein PT, Loberiza FR Jr. Association between race and survival of patients with non-small-cell lung cancer in the United States veterans affairs population. Clin Lung Cancer. 2014;15(2):152–8.PubMedCrossRef
29.
Zurück zum Zitat Fillmore NR, Yellapragada SV, Ifeorah C, et al. With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood. 2019;133(24):2615–8.PubMedPubMedCentralCrossRef Fillmore NR, Yellapragada SV, Ifeorah C, et al. With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood. 2019;133(24):2615–8.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat McKay RR, Sarkar RR, Kumar A, et al. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. Cancer. 2021;127(3):403–11.PubMedCrossRef McKay RR, Sarkar RR, Kumar A, et al. Outcomes of Black men with prostate cancer treated with radiation therapy in the Veterans Health Administration. Cancer. 2021;127(3):403–11.PubMedCrossRef
31.
Zurück zum Zitat Williams CD, Salama JK, Moghanaki D, Karas TZ, Kelley MJ. Impact of race on treatment and survival among U.S. veterans with early-stage lung cancer. J Thorac Oncol. 2016;11(10):1672–81.PubMedCrossRef Williams CD, Salama JK, Moghanaki D, Karas TZ, Kelley MJ. Impact of race on treatment and survival among U.S. veterans with early-stage lung cancer. J Thorac Oncol. 2016;11(10):1672–81.PubMedCrossRef
32.
Zurück zum Zitat Earles A, Liu L, Bustamante R, et al. Structured approach for evaluating strategies for cancer ascertainment using large-scale electronic health record data. JCO Clin Cancer Inform. 2018;2:1–12.PubMedCrossRef Earles A, Liu L, Bustamante R, et al. Structured approach for evaluating strategies for cancer ascertainment using large-scale electronic health record data. JCO Clin Cancer Inform. 2018;2:1–12.PubMedCrossRef
35.
Zurück zum Zitat Butler DC, Petterson S, Phillips RL, Bazemore AW. Measures of social deprivation that predict health care access and need within a rational area of primary care service delivery. Health Serv Res. 2013;48(2 Pt 1):539–59.PubMedCrossRef Butler DC, Petterson S, Phillips RL, Bazemore AW. Measures of social deprivation that predict health care access and need within a rational area of primary care service delivery. Health Serv Res. 2013;48(2 Pt 1):539–59.PubMedCrossRef
37.
Zurück zum Zitat Samuel CA, Landrum MB, McNeil BJ, Bozeman SR, Williams CD, Keating NL. Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care. Am J Public Health. 2014;104(Suppl 4):S562-571.PubMedPubMedCentralCrossRef Samuel CA, Landrum MB, McNeil BJ, Bozeman SR, Williams CD, Keating NL. Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care. Am J Public Health. 2014;104(Suppl 4):S562-571.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Wong MS, Hoggatt KJ, Steers WN, et al. Racial/ethnic disparities in mortality across the Veterans Health Administration. Health Equity. 2019;3(1):99–108.PubMedPubMedCentralCrossRef Wong MS, Hoggatt KJ, Steers WN, et al. Racial/ethnic disparities in mortality across the Veterans Health Administration. Health Equity. 2019;3(1):99–108.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Williams CD, Alpert N, Redding TS, et al. Racial differences in treatment and survival among veterans and non-veterans with stage I NSCLC: an evaluation of Veterans Affairs and SEER-Medicare populations. Cancer Epidemiol Biomarkers Prev. 2020;29(1):112–8.PubMedCrossRef Williams CD, Alpert N, Redding TS, et al. Racial differences in treatment and survival among veterans and non-veterans with stage I NSCLC: an evaluation of Veterans Affairs and SEER-Medicare populations. Cancer Epidemiol Biomarkers Prev. 2020;29(1):112–8.PubMedCrossRef
40.
Zurück zum Zitat Lee S, Reha JL, Tzeng CW, et al. Race does not impact pancreatic cancer treatment and survival in an equal access federal health care system. Ann Surg Oncol. 2013;20(13):4073–9.PubMedCrossRef Lee S, Reha JL, Tzeng CW, et al. Race does not impact pancreatic cancer treatment and survival in an equal access federal health care system. Ann Surg Oncol. 2013;20(13):4073–9.PubMedCrossRef
42.
Zurück zum Zitat Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital status and survival in pancreatic cancer patients: a SEER based analysis. PLoS ONE. 2011;6(6):e21052.PubMedPubMedCentralCrossRef Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital status and survival in pancreatic cancer patients: a SEER based analysis. PLoS ONE. 2011;6(6):e21052.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Swords DS, Mulvihill SJ, Brooke BS, Firpo MA, Scaife CL. Size and importance of socioeconomic status-based disparities in use of surgery in nonadvanced stage gastrointestinal cancers. Ann Surg Oncol. 2020;27(2):333–41.PubMedCrossRef Swords DS, Mulvihill SJ, Brooke BS, Firpo MA, Scaife CL. Size and importance of socioeconomic status-based disparities in use of surgery in nonadvanced stage gastrointestinal cancers. Ann Surg Oncol. 2020;27(2):333–41.PubMedCrossRef
44.
Zurück zum Zitat Murphy MM, Simons JP, Hill JS, et al. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma. Cancer. 2009;115(17):3979–90.PubMedCrossRef Murphy MM, Simons JP, Hill JS, et al. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma. Cancer. 2009;115(17):3979–90.PubMedCrossRef
45.
Zurück zum Zitat Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;16(3):546–52.PubMedCrossRef Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007;16(3):546–52.PubMedCrossRef
Metadaten
Titel
Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration
verfasst von
Jonathan Pastrana Del Valle, MD
Nathanael R. Fillmore, PhD
George Molina, MD, MPH
Mark Fairweather, MD
Jiping Wang, MD, PhD
Thomas E. Clancy, MD
Stanley W. Ashley, MD
Richard D. Urman, MD
Edward E. Whang, MD
Jason S. Gold, MD
Publikationsdatum
10.01.2022
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 5/2022
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-11250-0

Neu im Fachgebiet Chirurgie

Kein Unterschied bei inadäquaten Schocks zwischen ICD-Typen

Inadäquate Schockabgaben sind ein unerwünschter Effekt der Therapie mit implantierbaren Kardioverter-Defibrillatoren. Subkutanen Geräten haftet dabei der Ruf an, dafür besonders anfällig zu sein. Die PRAETORIAN-Forschungsgruppe ist dem nachgegangen.

DCIS: Ist ein Verzicht auf eine Operation möglich?

Die COMET-Studie zeigt, dass aktives Monitoring bei Patientinnen mit duktalem Carcinoma in situ (DCIS) hinsichtlich der kumulativen Zwei-Jahres-Rate an ipsilateralen invasiven Karzinomen der leitliniengerechten Standardbehandlung nicht unterlegen ist. Dennoch wird von einem Verzicht auf eine Operation abgeraten, wie in einem begleitenden Editorial betont wird.

Soll man bei Cholezystektomie routinemäßig cholangiografieren?

Eine US-Studie scheint den Befürwortern einer routinemäßigen intraoperativen Cholangiografie im Rahmen einer Cholezystektomie Recht zu geben. Die Studienkommentatoren in JAMA Surgery sparen jedoch nicht mit Kritik.

Langzeitdaten zur GERD-Kontrolle mittels Magnetband

Ergebnisse einer Postzulassungsstudie und weitere Daten sprechen dafür, dass die magnetische Sphinkter-Augmentation (MSA) eine sichere und effektive Therapieoption bei Refluxkrankheit darstellt.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.